The new facility will be able to produce two million doses per month. Mia Rabson, The Canadian Press
02/02/2021 11:38am EST
| Updated February 2, 2021
Alastair Grant/The Associated Press via The Canadian Press
A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for trial use in London on Oct. 7, 2020. The Novavax COVID-19 vaccine is likely at least two months away from being approved in Canada.
OTTAWA Prime Minister Justin Trudeau announced a tentative deal Tuesday with U.S. vaccine-maker Novavax to produce its product in Canada if the COVID-19 vaccine gets approved for use here.
“This is a major step forward to get vaccines made in Canada, for Canadians,” Trudeau said.
Canada signs deal with Novavax to make its COVID-19 vaccine at new Montreal facility - Medicine Hat NewsMedicine Hat News
medicinehatnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicinehatnews.com Daily Mail and Mail on Sunday newspapers.
Canada signs deal with Novavax to make its COVID-19 vaccine at new Montreal facility - Canada News
castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.